Bismuth News and Research

RSS

Appropriate timing in the use of breast shields in children can further reduce MDCT radiation dose

Appropriate timing in the use of breast shields in children can further reduce MDCT radiation dose

Using breast shields during pediatric chest MDCT reduces radiation dose and minimally increases image noise, according to a recent study conducted by researchers at Duke University Medical Center in Durham, NC and the University of Arkansas for Medical Sciences and Arkansas Children's Hospital in Little Rock.

13 Feb 2008

New cements for vertebral lesions

New cements for vertebral lesions

A number of researchers at the Department of Polymer Science and Technology at the Chemistry Faculty from San Sebastian at the University of the Basque Country, led by Ms Isabel Goni and Ms Marilo Gurrutxaga, are studying new formulae for acrylic copolymers and compounds in order to obtain efficacious, multiuse bone cements with reduced side effects.

8 Feb 2008

FDA warns against use of "bismacine," also known as chromocine

FDA warns against use of "bismacine," also known as chromocine

The U.S. Food & Drug Administration (FDA) is warning consumers and health care providers not to use a product called "bismacine," also known as chromocine.

21 Jul 2006

Levofloxacin-based triple therapy against persistent ulcer-inducing bacteria successful

Levofloxacin-based triple therapy against persistent ulcer-inducing bacteria successful

For those who suffer from stomach ulcers, the daily routine of breakfast, lunch and dinner can be painful.

10 May 2006

New treatment against persistent ulcer-inducing bacteria successful

New treatment against persistent ulcer-inducing bacteria successful

For those who suffer from stomach ulcers, the daily routine of breakfast, lunch and dinner can be painful. A common cause of these ulcers, as well as other gastric malignancies, is a bacterium called Helicobacter pylori .

1 May 2006

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.